Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis
Hunain Shiwani(Leeds Teaching Hospitals NHS Trust), James Moon(University of Michigan), Camilla Torlasco(IRCCS Istituto Auxologico Italiano), Warren J. Manning(Beth Israel Deaconess Medical Center), Harold Litt(University of Pennsylvania), Constantin‐Cristian Topriceanu(University College London), Peter Kellman(National Institutes of Health), Clara Badia-Molins(Universitat Autònoma de Barcelona), Lia Crotti(IRCCS Istituto Auxologico Italiano), Betty Raman(University of Leicester), Luís R. Lopes(Barts Health NHS Trust), Christopher M. Kramer(American College of Cardiology), João B. Augusto(Hospital Prof. Dr. Fernando Fonseca), Benjamin Dowsing(Barts Health NHS Trust), Anjali Owens(University of Pennsylvania), Walter R. Witschey(University of Pennsylvania), Saidi Mohiddin(St Bartholomew's Hospital), Rebecca Hughes(St Bartholomew's Hospital), Gabriella Captur(Royal Free London NHS Foundation Trust), Raffaello Ditaranto(Barts Health NHS Trust), George Joy(St Bartholomew's Hospital), Victor A. Ferrari, Alun D. Hughes(Aberystwyth University), Rhodri Davies(Barts Health NHS Trust), Jessica Artico(University of Trieste), Elena Biagini, José F. Rodríguez‐Palomares(Universitat Autònoma de Barcelona), Raymond Y. Kwong(Broad Institute), Mario Cortina‐Borja(Great Ormond Street Hospital), Inês Miranda(Hospital Prof. Dr. Fernando Fonseca), Carolyn Y. Ho(Brigham and Women's Hospital), Michael L. Chuang(Dana (United States))
Cited by 40
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k